The News Review:
- Legacy Appoints Vice President of Sales and Marketing, Europe, Middle…
- Obeo Names Alan Earl as Senior VP of Sales and Marketing
- Bloomberg.com: Investment Tools
- ViewCast Reports 2007 Fourth-Quarter & Year-End Financial Results
Legacy Appoints Vice President of Sales and Marketing, Europe, Middle…
Earthtimes.org – Mar 28, 2008
Paul Vaughan-Griffiths has over 30 years’ experience in the Pharmaceutical Industry. Prior to joining Legacy he was Head of Commercial European Operations in Prostrakan Ltd where he was involved in building the European business and for 10 years with Valeant Pharmaceuticals, previously ICN where he was Vice President Sales, Marketing and Business Development and built the European Pharmaceutical Business achieving sales growth from $30 million to $250 million. He also spent 20 years working for American Cyanamid, Lederle Laboratories holding various sales, marketing and General Management positions in Europe and the United States. Vaughan-Griffiths will be based at the Company’s European headquarters in Basel, Switzerland. About Legacy Pharmaceuticals Legacy Pharmaceuticals International GmbH is a customer-focused contract manufacturing and generic pharmaceutical company specializing in global manufacturing of prescription, over-the-counter (OTC), generic and cosmetic products at its plants in Humacao, Puerto Rico and Basel, Switzerland. More information about Legacy can be found at.
Obeo Names Alan Earl as Senior VP of Sales and Marketing
RisMedia.com – Mar 28, 2008
In that capacity, Earl will oversee the global sales and marketing initiatives of this industry-recognized real estate technology and marketing leader. “Alan comes to Obeo with a wealth of sales and sales management experience,” said Brent Gray, Obeo COO. “He is an extraordinarily driven individual who is passionate about growing businesses and loves working with people. We are extremely excited to welcome him to the Obeo team and look forward to incredible results in our sales department. ”Prior to joining Obeo, Earl worked as vice president of marketing and partner with ClearLink, a national company specializing in paid-television service, high-speed Internet and home security… In that capacity, Earl will oversee the global sales and marketing initiatives of this industry-recognized real estate technology and marketing leader. “Alan comes to Obeo with a wealth of sales and sales management experience,” said Brent Gray, Obeo COO. “He is an extraordinarily driven individual who is passionate about growing businesses and loves working with people. We are extremely excited to welcome him to the Obeo team and look forward to incredible results in our sales department. ”Prior to joining Obeo, Earl worked as vice president of marketing and partner with ClearLink, a national company specializing in paid-television service, high-speed Internet and home security. Earl also held positions at Northwestern Mutual Financial Network and Colonial Life and Accident Insurance Company.
Related: No ’small potatoes’ for marketing
Bloomberg.com: Investment Tools
Bloomberg – Mar 28, 2008
IOL product line to profitability — Obtained New Technology Intraocular Lens (NTIOL) approval from the Centers for Medicare and Medical Services (CMS) for Afinity Collamer(R) Aspheric Three-Piece IOL — Submitted NTIOL application to CMS for STAAR Collamer Aspheric Single Piece IOL which can be injected through a 2. 2 mm incision with the recently introduced nanoPOINT(TM) delivery system. STAAR Japan Highlights — Sales for the quarter were $2. 8 million which is on track to exceed $12 million for the year. — Business transferred from exclusive distributor to direct distribution without losing a customer. — End user pricing maintained which is the platform for gross margin improvement. — Costs are under control and on budget… , partially offset by non-recurrence of the expenses of theDomilens investigation in Q1 2007. Marketing and selling expenses were $6,467,000, which represents a 22%increase over the first quarter of 2007 of $5,302,000. Internationalmarketing and selling expenses increased 60% due to incremental costs of STAARJapan of $875,000, increased marketing and selling costs to drive continuedsales growth internationally, and the effect of exchange. marketing andselling expenses decreased 14% as compared to the first quarter of 2007 due todecreased commissions and promotional activities partially offset by increasedsalaries of the recently created direct sales force.
ViewCast Reports 2007 Fourth-Quarter & Year-End Financial Results
sys-con.com – Mar 31, 2008
That demand is being reflected in ViewCast’s product sales, which is shifting toward its Niagara line of fully integrated encoding systems that include front-end capture and back-end management software. According to Stoner, those factors are characteristics of a maturing market, where demand is for complete, cost-effective capability rather than new technology to simply enhance a function. ViewCast marketing and sales management has noted that sales are being motivated by business considerations more so than technology per se, the implication being that investing in enabling hardware for streaming over the Internet is increasingly becoming an important part of companies’ business plans. That view appears to be supported by rising demand for streaming capabilities and the competitive performance of ViewCast’s capture cards and encoder product lines. “To-date our new pricing policy has met with success, and we feel this is indicative not only the quality and performance benefits of our Osprey and Niagara product lines but also general market demand for streaming programming over the Internet,” Stoner stated. “With this in mind, we feel that our larger and more aggressive sales and marketing team, active partnerships with industry leaders, and favorable industry conditions offer substantial opportunities for stronger sales growth in 2008 than in recent periods and past years. Latham stated that revenue growth in 2007 was driven primarily by sales of Niagara encoding systems, which grew 41 percent over 2006 and accounted for more than 40 percent of revenues, compared to 33 percent of revenues in 2006.
Related: Bloomberg.com: Investment Tools